Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150
Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…
CertaraMarch 24, 2023
Tips & tricks for optimizing your pharmacokinetic modeling & simulation
Learn how to streamline your PK/PD workflows with expert tips.
CertaraMarch 23, 2023
Tips & tricks for streamlining non-compartmental pharmacokinetic analysis
These Phoenix tips and tricks will help you exclude Lambda Z, name partial areas, and…
CertaraJanuary 20, 2023
The Phoenix workflow shortcuts every pharmacokineticist needs
Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD…
CertaraDecember 16, 2022
Tips & tricks for data management in Phoenix WinNonlin
Learn some tips & tricks for the Data Wizard, a data management tool in Phoenix,…
CertaraNovember 18, 2022
Tips to use Phoenix WinNonlin more efficiently
Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform is the single, interoperable hub for sharing pre-clinical…
CertaraNovember 7, 2022
Simcyp® Discovery Simulator
Tailored for discovery and translational scientists, Simcyp® Discovery Simulator is an intuitive software that delivers…
CertaraJuly 14, 2022
